PulteGroup is delivering a sharp post-earnings bounce, yet short sellers are adding at their fastest pace in months — a divergence that frames the week's central tension.
The stock gained 8.4% over the past week to close at $134.75, making it an outperformer among homebuilder peers. LEN rose 7.1% and DHI added 5.3%, while MTH lagged the group with a gain of just 2.2%. PHM's one-day move of 3.2% on Tuesday outpaced most of the space on the same session. The Q2 print — which triggered only a 0.3% next-day gain — has been followed by a grinding continuation rally, in contrast to the Q1 result, which sent the stock down 2.1% on the day.
Short interest is rising into that strength, which is the more interesting signal this week. Shorts climbed 13.5% over the past seven days to reach 5.3% of the free float — the highest level in at least two months, and up roughly 21% over the past month. That grind began in late June, continued through the Q2 report on July 22, and has accelerated since. The ORTEX short score ticked up to 46.0 on July 28, its highest reading of the 10-day history available, having climbed from 41.8 in mid-July. The borrow market offers no friction to slow the build: availability is extremely loose at roughly 1,348% of short interest, meaning the lending pool has roughly 14 shares available for every one currently borrowed. Cost to borrow eased slightly to 0.48% this week. Short sellers face no mechanical squeeze pressure; the rebuild is deliberate, not distressed.
Options positioning has cooled after a notably defensive stretch earlier in July. The put/call ratio is now 1.07, essentially flat with its 20-day average of 1.08, giving a z-score near zero. That's a meaningful shift from the 1.24–1.26 range that prevailed around July 22–24, when options traders were hedging into the Q2 number. The retreat in the PCR toward the mean suggests that hedging demand has normalised post-print — which makes the continued short build in the lending market the cleaner expression of residual bearishness.
The Street is split, and the post-earnings analyst reaction captures the tension precisely. Evercore ISI raised its target to $162 from $151 and kept its Outperform, while Wells Fargo holds at Overweight with a $150 target. Both see upside from current levels. Citigroup, however, lowered its target to $134 from $138 just one day after the print, keeping a Neutral rating — essentially saying the stock is now fairly valued at its current price. RBC and Barclays made token upward adjustments to $116 and $124 respectively, both sitting meaningfully below where PHM trades today. The consensus mean target of $140.61 implies modest upside, but the distribution of targets is wide: at least two major firms think the stock is at or past fair value right now. The bear case centres on order declines of around 9% year-over-year forecast for Q3 and Q4, a significant downward revision from earlier guidance of -2% to -3%, alongside affordability headwinds that bulls acknowledge but expect the active adult segment to partially offset. On valuation, PHM trades at roughly 12.5x trailing earnings and 8.9x EV/EBITDA — both multiples drifted modestly higher this week with the price move. The EPS momentum factor score of 69 on a 30-day basis provides some fundamental support for bulls.
Institutional ownership is broadly passive and stable — BlackRock holds 10.3% and Vanguard-related entities collectively account for roughly 11% — so near-term flow is unlikely to come from that direction. Insider activity over the past 90 days has been exclusively on the sell side, with the COO selling twice in May and the CEO selling $14.9 million of stock in February at around $134, almost exactly where the stock trades today. The net insider figure for the 90-day period is technically positive at roughly 19,750 shares, but that appears to be a netting effect of option grants or awards rather than open-market buying. There is no material insider accumulation to set against the short build.
The next earnings date is October 20. Between now and then, the data to watch is whether the short rebuild continues at its current pace — adding roughly 1.2 million shares a week — or whether the post-Q2 rally forces some of that positioning to be unwound. The gap between where the bulls and bears are anchoring their price targets, and the divergence between a rising stock and rising short interest, means the back-half order trends management flagged will determine which side of that debate gets resolved first.
See the live data behind this article on ORTEX.
Open PHM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
